Research on the mechanism of GRIM-19 affecting lung adenocarcinoma through regulating MDM2 and EMT pathways

Pengfei Guo1, Song Zhao1, Xiaoli Han1

  • 1Department of Thoracic Surgery, Affiliated Hospital of Chengde Medical University, Chengde, China.

Cytotechnology
|July 2, 2025
PubMed

Insights

Growth arrest and DNA-damage-inducible protein 19 (GRIM-19) inhibits lung adenocarcinoma progression by suppressing MDM2 expression. This study reveals GRIM-19

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Lung adenocarcinoma is characterized by decreased GRIM-19 and increased MDM2 expression.
  • The specific relationship between GRIM-19 and MDM2 in lung adenocarcinoma remains unelucidated.

Purpose of the Study:

  • To investigate the correlation between GRIM-19 and MDM2 in lung adenocarcinoma.
  • To explore the functional role of GRIM-19 in lung adenocarcinoma progression and metastasis.

Main Methods:

  • Analysis of GRIM-19 and MDM2 mRNA expression in lung adenocarcinoma tissues.
  • Pearson correlation analysis to determine the relationship between GRIM-19 and MDM2.
  • Experimental validation of GRIM-19's effect on MDM2 protein levels and lung adenocarcinoma cell behavior (proliferation, invasion, migration, apoptosis) in vitro and in vivo.
  • Assessment of epithelial-mesenchymal transition (EMT) markers following GRIM-19 overexpression.

Main Results:

  • GRIM-19 mRNA expression was significantly reduced, while MDM2 mRNA expression was increased in lung adenocarcinoma.
  • A strong negative correlation (r = -0.970, p < 0.001) was observed between GRIM-19 and MDM2 mRNA levels.
  • Overexpression of GRIM-19 decreased MDM2 protein levels, inhibited cell proliferation, invasion, and migration, promoted apoptosis, and suppressed tumor growth in nude mice.
  • GRIM-19 modulated the expression of EMT markers (Snail, N-Cadherin, E-Cadherin, Vimentin), suggesting regulation of the EMT pathway.

Conclusions:

  • GRIM-19 plays a crucial role in inhibiting lung adenocarcinoma development and progression.
  • GRIM-19 may exert its tumor-suppressive effects by downregulating MDM2 expression and inhibiting the EMT pathway.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.2K